in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
USPTO Grants Codexis Patent for Enzymes Used in Hepatitis-C Therapeutics
12:45 AM MDT | May 17, 2012 | Deepti Ramesh
Codexis (Redwood City, CA) says that the United States Patent and Trademark Office (USPTO; Alexandria, VA) has granted Codexis’ patent covering the biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of hepatitis-C therapeutics. The term of this patent does not expire until 2029. The patent is titled “Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds” and was issued as U.S. patent number 8,178,333. “This patent specifically...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee